CompuGroup Medical confirms guidance and mid-term growth targets at virtual Annual General Meeting

CompuGroup Medical SE & Co. KGaA – one of the leading e-health companies in the world – today successfully held its virtual Annual General Meeting (AGM). The resolutions on the dividend payment, the purchase and use of treasury shares, the remuneration system and the discharge of the executive and supervisory boards were passed with convincing majorities. The management confirmed the guidance for the current year and mid-term growth targets. 

The attendance at today’s AGM, which was held as a virtual meeting for the second time due to the ongoing COVID-19 pandemic, was about 83 % of total share capital. The resolution on the appropriation of profits including the proposed dividend of EUR 0.50 was passed with a majority of 99.9 %. The AGM also passed resolutions on the approval of the actions of the former Management Board, the current General Partner and the former and the current Supervisory Boards, the purchase and use of treasury shares and the remuneration system for the Managing Directors and Supervisory Board, each with convincing majorities of more than 75 % of the votes. 

“CompuGroup Medical achieved record revenues of EUR 837 million in the financial year 2020 – a remarkable increase of 12 %. At the same time, the adjusted EBITDA increased by 8 % to EUR 215 million,” said CEO Dr. Dirk Wössner and added, “Worldwide, the COVID-19 pandemic has proven in a dramatic way how crucial well-functioning, efficient healthcare is, and which opportunities arise from digitization of the processes, data processing and information exchange. Many governments have recognized the urgent need for action and have set up large investment programs in the billions, in some cases.” 

In his speech, Dirk Wössner confirmed the guidance for the current financial year, envisaging more than EUR 1 billion in revenues and an adjusted EBITDA in the range of EUR 210 – 230 million. And he emphasized that CGM is targeting significant growth in the future from enhancing services for healthcare professionals with new functionalities, patient portals, synergies and scale effects from the two large acquisitions in the hospital business and the US market, from additional modules in Telematics Infrastructure, new data services and by digitization initiatives such as the Hospital Future Act in Germany. 

Dirk Wössner: “Beyond 2021, we expect annual organic revenue growth of 5 % and more with the EBITDA margin increasing again at the same time.” 

Information on the AGM including the full voting results is available at www.cgm.com/agm.